GenCell Biosystems
GenCell Biosystems is developing revolutionary technologies for molecular biology. GenCell Biosystems is commercializing a number of instruments based upon their innovative Composite Liquid Cell platform technology. Composite Liquid Cells (CLCs) provide an entirely new method of confining, transporting, combining, processing and analysing biological reactions to yield valuable data. With applications including sample extraction and preparation, library preparation for next-gen sequencing, PCR genotyping, qPCR, digital PCR and proteomic assays, CLCs are versatile and can be tailored to suit virtually all protocol requirements.
Industries
biotechnology
clinical-trials
genetics
health-care
manufacturing
Nr. of Employees
medium (51-250)